This is an equipment w/warranty contract for a spotfire instrument required to validate the proficiency test kits produced by the molecular diagnostics department.

Ended Purchase Order Awarded

Contract number
N3239826P0302
Awardee
Awarding agency
Obligated
$60,835

Award facts

Opportunity
  • N3239826Q3522 Solicitation number
Contract value 100% obligated
$60,835.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325413 In-Vitro Diagnostic Substance Manufacturing
PSC
6640 Laboratory Equipment And Supplies
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Frederick, MD 21702, USA

Award details come from SAM.gov/FPDS.

About this award

The U.S. Department of Defense's Bureau of Medicine and Surgery awarded Biofire Defense LLC a $60.8K firm fixed-price purchase order on October 27, 2025, for a Spotfire instrument equipped with warranty coverage. The equipment is required by the Molecular Diagnostics Department to validate proficiency test kits, with completion targeted for November 28, 2025. The contract was awarded without a set-aside designation and will be performed in Frederick, Maryland. This procurement aligns with Biofire Defense's established role as a specialized federal vendor in molecular diagnostic technologies, leveraging the company's expertise in rapid pathogen identification systems and biodefense applications.

Biofire Defense LLC, a Salt Lake City-based manufacturer of molecular diagnostic technologies registered as a federal contractor since 2001, brings extensive experience in supporting Department of Defense biodefense and infectious disease detection missions. The company currently holds multiple active contracts with the Defense Health Agency and Department of the Army, including an $8.3M Other Transaction Agreement for validation of the Environmental Film Array Next Generation Diagnostic System Sentinel Panel designed for Spotfire system integration. This targeted equipment award builds upon Biofire Defense's comprehensive federal contract portfolio, which emphasizes rapid diagnostic solutions and molecular analyzer systems critical to military medical readiness and public health preparedness objectives.

Quick answers

Who was awarded contract N3239826P0302?

N3239826P0302 was awarded to Biofire Defense LLC by Bureau of Medicine and Surgery (Department of the Navy) on October 27, 2025.

How much is contract N3239826P0302 worth?

The government has obligated $60,835 on N3239826P0302.

Was contract N3239826P0302 competed?

The extent of competition for N3239826P0302 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award